BPL manufactures protein therapeutics for the treatment of patients around the globe who have serious and life-threatening conditions. These proteins are present in human blood and are isolated, purified and concentrated by BPL using plasma fractionation and purification technologies.
BPL embeds quality throughout all our processes, from welcoming plasma donors at our own licensed collection centres, through manufacturing and also tracking the safety and efficacy of our medicines in the patients who use them. The BPL quality management framework supports the safety of plasma and plasma products in line with internationally-accepted standards defined by UK, US and European government agencies and regulators.
Here's a short video describing the BPL Plasma Journey: